Immunoglobulin G4-Related Disease: all 69 studies
Page 1 of 1. Open to participants first (37), then studies with results posted, then the rest; newest registration first within each.
- Tripterygium Wilfordii Plus Prednisone for Active IgG4-Related DiseaseNot yet recruitingNCT07878585Phase 2
- Nebulized UC-EVs for Recurrent or Refractory IMIDs With Lung InvolvementNot yet recruitingNCT07806045Early Phase 1
- BCT301 in Treating Refractory/Recurrent IgG4-related DiseaseNot yet recruitingNCT07793903Not applicable
- Efficacy and Safety of Lenalidomide in Patients With IgG4-Related DiseaseNot yet recruitingNCT07719543Phase 3
- A Study of IMM0306 in IgG4-Related DiseaseNot yet recruitingNCT07621939Phase 2/3
- A Study to Evaluate MTM-H-001 Injection in Adult Patients With B-Cell-Related Autoimmune DiseasesNot yet recruitingNCT07593911Not applicable
- Validation of the Odesa Criteria 2026 for Autoimmune PancreatitisRecruitingNCT07536841
- The Investigators Will Evaluate the Diagnostic Performance of [18F]-AlF-FAPI-74 PET/CT in Inflammatory Disorders and Compare it With the Current Gold Standard for Inflammation, FDG PET/CT, in Three Patient Cohort: Patients Presenting With Fever of Unknown Origin, IgG4-RD and AxSpA.RecruitingNCT07535554Phase 2/3
- An Exploratory Clinical Study on the Safety and Efficacy of CD19/BCMA CAR-NK in the Treatment of Relapsed and Refractory IgG4-related DiseaseNot yet recruitingNCT07298590Early Phase 1
- Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Inebilizumab in Pediatric Participants With IgG4-RDNot yet recruitingNCT07222553Phase 2
- A 52-week Study of Rilzabrutinib Efficacy and Safety Compared to Placebo in Adults Diagnosed With IgG4-related DiseaseRecruitingNCT07190196Phase 3
- Exploratory Study of Anti-BCMA-CD19 CAR-T Cell Therapy in Relapsed or Refractory IgG4-Related DiseaseRecruitingNCT07148791Phase 2
- A Study on the Effect of MRD Detected by FAPI PET / CT on the Recurrence of IgG4-RDRecruitingNCT07104058Not applicable
- A Randomized Controlled Study of the Efficacy and Safety of Lenalidomide in the Treatment of Active IgG4-related DiseaseRecruitingNCT07068165Phase 2/3
- Study to Assess Safety, Efficacy and Persistence of ACE1831, in Subjects With IgG4-Related DiseaseRecruitingNCT07061938Phase 1/2
- A Clinical Study of YTS109 Cell in R/R Autoimmune DiseasesRecruitingNCT06978647Phase 1
- BCMA-CD19 CAR-T Therapy for Refractory Autoimmune DiseasesRecruitingNCT06794008Phase 2
- AYLo - AutoimmunitY and Loss of yRecruitingNCT06696027
- Short-term Glucocorticoid Combined with MMF for IgG4-RDRecruitingNCT06663618Not applicable
- Key Mechanisms of Abnormal T Cell Activation and Differentiation in IgG4-Related Ophthalmic DiseaseNot yet recruitingNCT06655831
- Institutional Registry of Rare DiseasesRecruitingNCT06573723
- Safety and Efficacy of PRG-1801 for Refractory Lupus Nephritis and IgG4-Related DiseaseRecruitingNCT06497387Early Phase 1
- Safety and Efficacy of PRG-2311 for Refractory Lupus Nephritis and IgG4-Related DiseaseRecruitingNCT06497361Early Phase 1
- Early Clinical Study of UTAA09 Injection in the Treatment of Relapsed/Refractory Autoimmune DiseasesRecruitingNCT06361745Not applicable
- Drug Rediscovery for Rare Immune Mediated Inflammatory DiseasesRecruitingNCT06285539Phase 2
- The BCMA/CD19 Dual Targeted CAR-T Cell in Participants With Autoimmune Kidney DiseasesRecruitingNCT06285279Phase 1
- Study of the C5a/C5aR1 Axis in IgG4-associated Disease: a Potential Therapeutic TargetNot yet recruitingNCT06270524Not applicable
- Diagnostic and Prognostic Biomarkers for IgG4-related Disease.RecruitingNCT05901207
- Treatment Strategies for IgG4-RD Patients With Superficial Organ InvolvementRecruitingNCT05789030Not applicable
- Baricitinib Plus Glucocorticoid for Eosinophilia in IgG4-RDRecruitingNCT05781516Not applicable
- Study of Sirolimus in IgG4-related DiseaseNot yet recruitingNCT05746689Not applicable
- Immunoglobulin G4 and Immunoglobulin E Antibodies in a Population With Adverse Reactions to Foodstuffs-related SymptomsRecruitingNCT05681975
- Tofatib Treatment for IgG4-related DiseaseRecruitingNCT05625581
- Meir Medical Center Rheumatologic BiobankRecruitingNCT03473912
- National Registry of IgG4-RD in ChinaRecruitingNCT03023371
- Comparative Autoantibody and Immunologic Cell Marker StudyEnrolling by invitationNCT02422875
- A Prospective Cohort Study of IgG4RD in ChinaRecruitingNCT01670695
- Elotuzumab in Immunoglobulin G4-Related Disease (IgG4-RD)TerminatedNCT04918147Phase 2Results posted
- Zanubrutinib in Patients With IgG4-Related DiseaseCompletedNCT04602598Phase 2Results posted
- A Study of Inebilizumab Efficacy and Safety in IgG4- Related DiseaseActive, not recruitingNCT04540497Phase 3Results posted
- Safety and Efficacy of Abatacept in IgG4-Related DiseaseCompletedNCT03669861Phase 2Results posted
- Study to Evaluate the Effect of XmAb®5871 on Disease Activity in Patients With IgG4-Related Disease (RD)CompletedNCT02725476Phase 2Results posted
- Tofacitinib in the Treatment of IgG4 Related DiseasesCompletedNCT07827469Not applicable
- A Clinical Study to Evaluate LVIVO-TaVec400 for the Treatment of Relapsed/Refractory Autoimmune DiseasesWithdrawnNCT07583030Early Phase 1
- the Safety and Efficacy of Targeted BCMA In Vivo LV Injection for Recurrent or Refractory Autoimmune DiseasesActive, not recruitingNCT07339540Early Phase 1
- A Study of Efgartigimod in Patients With IgG4-Related DiseaseActive, not recruitingNCT07025330Phase 2
- Adaptive and Trained Immunity in the Pathogenesis of IgG4-Related DiseaseActive, not recruitingNCT06844864
- Treatment Strategies in IgG4-RD Patients With Re-elevation of Serum IgG4 Level During Maintenance Remission PeriodStatus unknownNCT05974683Not applicable
- Study to Evaluate the Efficacy and Safety of CM310 in Subjects With IgG4-related DiseaseStatus unknownNCT05728684Not applicable
- A Phase 3 Study of Obexelimab in Patients With IgG4-Related DiseaseActive, not recruitingNCT05662241Phase 3
- Impact of COVID-19 on the Clinical Outcomes and Management of IgG4 Related Disease PatientsCompletedNCT04817553
- Belimumab Treatment for IgG4-related DiseaseStatus unknownNCT04660565Phase 4
- Circulating Plasmablast in Diagnosis and Relapse Prediction of IgG4-RDStatus unknownNCT04539197
- Open Label Two-Arm Study to Evaluate Rilzabrutinib in IgG4-Related Disease ParticipantsCompletedNCT04520451Phase 2
- Characterizing IgG4-RD With 68Ga-FAPI PET/CTStatus unknownNCT04125511Early Phase 1
- Withdraw Drug in Stable IgG4-Related DiseaseStatus unknownNCT04124861Not applicable
- Infraorbital Nerve Involvement on Magnetic Resonance Imaging in IgG4-related Ophthalmic DiseaseCompletedNCT03690908
- Plasmablast Detection From IgG4-Related Disease PatientsStatus unknownNCT03466970
- To Evaluate the Clinical Efficacy of Iguratimod in the Treatment of IgG4 Related Disease (IgG4-RD) With Mild SymptomStatus unknownNCT03368274Phase 4
- A Laboratory Scan of Patients With Aortic Aneurysms to IgG4 Levels in the BloodStatus unknownNCT03267875Not applicable
- Follicular Helper T Cells: Biological Marker and Involvement in the Physiopathology of the IgG4-related DiseaseCompletedNCT02899039Not applicable
- Characterization of Tissular T Follicular Helper Cells in IgG4-RDCompletedNCT02872441Not applicable
- Treatment of IgG4-Related Disease With Revlimid and RituximabCompletedNCT02705638Phase 1
- Leflunomide for Maintenance of Remission in IgG4 Related DiseaseCompletedNCT02703194Phase 4
- Bile Usefulness for Detecting IgG4-related Sclerosing CholangitisCompletedNCT02616705
- Study of Treatment Response on IgG4 Related Disease (IgG4RD)Status unknownNCT02458196Phase 2
- Retrospective Study for Diagnosis of Undetected IgG4 Related Diseases in Patients With High Serum IgG4 Levels.CompletedNCT02229448
- Glucocorticoids in Patients With IgG4-RDStatus unknownNCT01758393Phase 2/3
- 18F-FDG PET/CT for IgG4-Related DiseaseStatus unknownNCT01665196Early Phase 1